Cancer Communications

Article	Citations
	493
Issue Information	459
Issue Information	285
Kindlin‐1 drives early steps of breast cancer metastasis	273
Correction to “Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges”	215
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy	199
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update	188
Current status and perspectives of esophageal cancer: a comprehensive review	185
Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study	176
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma	159
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation	156
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma	147
Issue Information	144
	143
Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity	126
Nine‐fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross‐sectional study in a large screening colonoscopy cohort	124
	121
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study	115
Issue Information	114
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives	114
Research trends of cancer metabolism: analysis from a Chinese perspective	111
Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward	107
Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions	101
	100
Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study	98

Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with h	92
	89
Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses	86
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5‐year update of the CinClare trial	85
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer	78
EXPRESSION OF CONCERN: Discovery of a Novel Viroid‐Like Circular RNA in Colorectal Cancer	77
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer	76
Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence	70
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinica	69
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer	67
Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial	62
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program	59
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity	54
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy	54
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases	53
N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis	53
Issue Information	51
Cover Image, Volume 45, Issue 6	50
	50
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials	50
Cover Image, Volume 42, Issue 1	48
	48
Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma	47
Incidence of and survival with bone and soft tissue sarcoma: A nation‐wide study over four decades	46
Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism	44
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer	44
Comprehensive DSRCT multi‐omics analyses unveil CACNA2D2 as a diagnostic hallmark and super‐enhancer‐driven EWSR1::WT1 signature gene	43
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial	43
FOXO1 or not FOXO1: that is the question	42
Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma	41
Harnessing chimeric antigen receptor macrophages against solid tumors	40
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia	40
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study	39
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation	39
A strong internal promoter drives massive expression of YEATS‐domain devoid MLLT3 transcripts in HSC and most lethal AML	38
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2	37
Ubiquitination in cancer: mechanisms and therapeutic opportunities	36
Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis	35
Correction to: ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3	34
Issue Information	34
Low household income and income volatility increase risk of lung cancer: A nationwide retrospective cohort study	34
Long‐term outcomes of intraoperative radiotherapy for early‐stage breast cancer in China: a multicenter real‐world study	33
Correction to “Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer”	32
m6A‐modified EHD1 controls PD‐L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma	31
Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences	31
Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure	31
An HGF‐dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis	31
Development of antibody‐drug conjugates in cancer: Overview and prospects	30
Breast cancer: an up‐to‐date review and future perspectives	30
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps	29

Genomic information of children with malignant brain tumors for the prediction of length of hospitalization	29
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas	27
4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists	27
Long‐term antibiotic use and risk of hepatocellular carcinoma later in life: a nationwide cohort study of 9.8 million participants	27
Inhibition of mTOR attenuates the initiation and progression of BRCA1‐associated mammary tumors	26
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA	26
Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients	25
Breaking barriers: the cGAS‐STING pathway as a novel frontier in cancer immunotherapy	25
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract	25
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer	25
Neuroinflammation drives apathy in cancer cachexia	25
Single‐cell and bulk transcriptomics identifies a tumor‐specific CD36+ cancer‐associated fibroblast subpopulation in colorectal cancer	24
	24
Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy	24
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines	24
Issue Information	24
Issue Information	24
Knowing nodal Rouviére: the power of human intelligence in toxicity reduction	24
Cover Image, Volume 44, Issue 4	23
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium	23
Breaking barriers: Smart vaccine platforms for cancer immunomodulation	23
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression	23
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms	23
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence	23
Galectin 3‐binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor‐β1 (TGF‐β1) availability and inhibits hepatocarcinogenesis	22
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study	22
Tumor microenvironment signaling and therapeutics in cancer progression	22
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins	22
Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy	20
	20
Cover Image, Volume 43, Issue 6	20
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment	20
Issue Information	20
Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy	20
Enhancing sensitivity of triple‐negative breast cancer to DNA‐damaging therapy through chemical inhibition of the m6A methyltransferase METTL3	19
Single‐cell‐eQTL mapping in circulating immune cells reveals genetic regulation of response‐associated networks in lung cancer immunotherapy	19
Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy	19
The regulatory roles and clinical significance of glycolysis in tumor	19
Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer	18
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors	18
	18
Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation	17
The SARS‐CoV‐2 spike protein induces lung cancer migration and invasion in a TLR2‐dependent manner	17
Evolution of tumor microenvironment in colorectal liver metastases under treatment stress	17
Issue Information	17
Perivascular localized cells commit erythropoiesis in PDGF‐B‐expressing solid tumors	17
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment	17
Proteomic identification of new diagnostic biomarkers of early‐stage cutaneous mycosis fungoides	17
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis	16
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer	16
Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China	16
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)	16
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinica	16
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients	16
	15
Issue Information	15
Discovery of a novel viroid‐like circular RNA in colorectal cancer	15
Ferroptosis in cancer and cancer immunotherapy	15
Diagnostic value of genetic mutation analysis and mutation profiling of cell‐free DNA in intraocular fluid for vitreoretinal lymphoma	15
Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors	15
RNA m1A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target	14
Unraveling the routes to distant metastases in colorectal cancer: Tumor deposits and lymph node metastases as the gateway	14
Transient and DNA‐free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis	14
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis	14
NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma	14
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma	13
Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor	13
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study	13
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial	13
Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types	13
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models	13
Cover Image, Volume 43, Issue 12	13
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma	12
Methionine restriction sensitizes cancer cells to immunotherapy	12
A phase II study on Mefatinib as first‐line treatment of patients with advanced non‐small‐cell lung cancer harboring uncommon EGFR mutations	12
Issue Information	12
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment	12
Combating cancer immunotherapy resistance: a nano‐medicine perspective	12
Exciting progress in targeted therapy innovation for unresectable stage III EGFR‐mutated NSCLC: the phase III LAURA study	12
Lung cancer risk score for ever and never smokers in China	12

Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer	12
Engineering heavy chain antibody‐drug conjugates against solid tumors for a one‐shot kill	12
Issue Information	12
Cover Image, Volume 42, Issue 6	11
Cover Image, Volume 43, Issue 9	11
	11
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity	11
Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets	11
Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphoma	11
Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinoma	10
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer	10
	10
MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response	10
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer	10
	10
Issue Information	10
CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer	10
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis	10
Vascular smooth muscle cell plasticity in the tumor microenvironment	10
Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47	9
Stereotactic body radiotherapy plus cadonilimab (PD‐1/CTLA‐4 bispecific antibody) as third‐line or beyond therapy for refractory solid tumors: A phase 1b study	9
Transcriptome‐wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma	9
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial	9
Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling	9
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023	9
Issue Information	9
Cover Image, Volume 43, Issue 11	8
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer	8
Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci	8
Cover Image, Volume 42, Issue 8	8
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors	8
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy	8
Intratumoral CD103+CD8+ T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma	8
Tumor derived cell‐free nucleic acid upregulates programmed death‐ligand 1 expression in neutrophil via intracellular Toll‐like receptor signaling	8
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy	8
Training the synergy between Bacillus Calmette‐Guérin and immune checkpoint‐blocking antibodies in bladder cancer	8
Cover Image, Volume 41, Issue 12	8
Cover Image, Volume 42, Issue 6	7
Issue Information	7
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study	7
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study	7
	7
Vitamin D3 for reducing mortality from cancer and other outcomes before, during and beyond the COVID‐19 pandemic: A plea for harvesting low‐hanging fruit	7
Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma	7
Unveiling quality of clinical trial in China: from concern to confirmation	7
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1	7
Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows	7
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates	7
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analyses	7
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells	7
NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4‐acetylated LAMB3‐mediated FAK/ERK pathway	7
Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib	7
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis	6
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors	6
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression	6
Issue Information	6
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit‐and‐run” paradigm	6
Parkin deficiency promotes colorectal tumorigenesis and progression through RIPK3‐dependent necroptotic inflammation	6
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis	6
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway	6
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modality	6
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies	6
Issue Information	6
The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma	6
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor	6
Issue Information	6
Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma	6
A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability	6
A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma	6
Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection	6
	6
	5
Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in precli	5
Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients	5
Exposure of benzo[a]pyrene induces HCC exosome‐circular RNA to activate lung fibroblasts and trigger organotropic metastasis	5
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy	5
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients	5
SALIRI‐based (raltitrexed plus irinotecan) therapy as a second‐line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non‐interventional, registry study	5
Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer	5
Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies	5
m6A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels	5
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response	5
Non‐small cell lung cancer in China	5
Issue Information	5
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy	5
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy	5
NAT10‐mediated ac4C‐modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear‐cell renal cell carcinoma by attenuating YWHAE‐driven cytoplasmic retention of YAP1	5
Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants	5
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions	4
Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer	4
	4
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors	4
Issue Information	4
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities	4
Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti‐PD‐1 immunotherapy efficacy in colorectal cancer liver metastasis	4